|
MechanismP2Y14 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Random Walk Ventures LLC
0 Patents (Medical) associated with Random Walk Ventures LLC
100 Deals associated with Random Walk Ventures LLC
100 Translational Medicine associated with Random Walk Ventures LLC